Virus-Based therapy takes on tough cancers in early trial
Disease control
Recruiting now
This early-phase study tests a new drug called OTS-412, made from a modified virus, alone or with other drugs, in 27 adults with advanced solid tumors that stopped responding to standard care. The main goal is to check safety and side effects, while also looking at whether tumors…
Phase: PHASE1 • Sponsor: Bionoxx Inc. • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC